Antiviral activity of aminocaproic acid against SARS-CoV-2: review of the literature and results of the first experimental study
BACKGROUND. The SARS-CoV-2 pandemic has a significant impact on the global health care system, so effective treatments for coronavirus disease (COVID-19) are urgently needed. Nowadays, drug repurposing is widely considered for COVID-19 therapy; significant attention is paid to inhibitors of transmem...
Saved in:
Main Authors: | J. Chiaravalli (Author), A. Verneuil (Author), V. Osiichuk (Author), D. Golyshkin (Author), O.Ya. Dziublyk (Author), M.I. Gumeniuk (Author), O.S. Denysov (Author) |
---|---|
Format: | Book |
Published: |
Civic Union "Communicable Diseases Intensive Care Association",
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled antiseptics and inhaled antiviral non-prescription drugs in the prevention of ARVI, in particular COVID-19: an epidemiological study
by: Yu.I. Feshchenko, et al.
Published: (2021) -
The impact of the COVID-19 pandemic on the financial sector in medicine: features of centralized state procurement of drugs and medical devices in Ukraine for the period 2018-2021
by: O.S. Denysov
Published: (2021) -
SARS-CoV-2 cell entry and targeted antiviral development
by: Zinuo Chen, et al.
Published: (2021) -
Systematic review and meta-analysis of tranexamic acid and epsilon aminocaproic acid in pediatric heart surgery
by: Lukasz Szarpak, et al.
Published: (2024) -
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022)